BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24918666)

  • 1. [Hereditary angioedema. Treatment of acute attacks in Argentina].
    Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
    Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hereditary angioedema due to C1 inhibitor deficiency in Argentina.
    Malbrán E; Menéndez A; Malbrán A
    Medicina (B Aires); 2017; 77(4):279-282. PubMed ID: 28825570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary angioedema. A therapeutic guide].
    Malbrán A; Fernández Romero DS; Menéndez A
    Medicina (B Aires); 2012; 72(2):119-23. PubMed ID: 22522852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic approaches in hereditary angioedema.
    Antoniu SA
    Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment options for acute edema attacks caused by hereditary angioedema.
    Thomas MC; Shah S
    Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
    Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
    N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
    Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
    Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 20. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.